195 related articles for article (PubMed ID: 11816130)
21. Comparison of the functional outcome after pylorus-preserving pancreatoduodenectomy: pancreatogastrostomy and pancreatojejunostomy.
Jang JY; Kim SW; Park SJ; Park YH
World J Surg; 2002 Mar; 26(3):366-71. PubMed ID: 11865376
[TBL] [Abstract][Full Text] [Related]
22. NTP technical report on the toxicity studies of Riddelliine (CAS No. 23246-96-0) Administered by Gavage to F344 Rats and B6C3F1 Mice.
Chan P
Toxic Rep Ser; 1993 Dec; 27():1-D9. PubMed ID: 12209179
[TBL] [Abstract][Full Text] [Related]
23. Fecal chymotrypsin and elastase-1 determination on one single stool collected at random: diagnostic value for exocrine pancreatic status.
Molinari I; Souare K; Lamireau T; Fayon M; Lemieux C; Cassaigne A; Montaudon D
Clin Biochem; 2004 Sep; 37(9):758-63. PubMed ID: 15329313
[TBL] [Abstract][Full Text] [Related]
24. Pylorus-preserving pancreatoduodenectomy: preoperative pancreatic function and outcome.
Ohuchida J; Chijiiwa K; Ohtsuka T; Konomi H; Tanaka M
Hepatogastroenterology; 2007; 54(75):913-6. PubMed ID: 17591091
[TBL] [Abstract][Full Text] [Related]
25. [Faecal elastase I--its use in diagnosis of chronic pancreatitis].
Krechler T; Kocna P; Vanícková Z; Svestka T; Lukás M; Dosedel J; Kohout P; Zák A
Cas Lek Cesk; 2006; 145(6):480-3. PubMed ID: 16836002
[TBL] [Abstract][Full Text] [Related]
26. Screening for pancreatic exocrine insufficiency in patients with diabetes mellitus.
Nunes AC; Pontes JM; Rosa A; Gomes L; Carvalheiro M; Freitas D
Am J Gastroenterol; 2003 Dec; 98(12):2672-5. PubMed ID: 14687815
[TBL] [Abstract][Full Text] [Related]
27. Management of maldigestion associated with pancreatic insufficiency.
Perry RS; Gallagher J
Clin Pharm; 1985; 4(2):161-9. PubMed ID: 3987214
[TBL] [Abstract][Full Text] [Related]
28. Influence of high-dose pancreatic enzyme treatment on pancreatic function in healthy volunteers.
Friess H; Kleeff J; Malfertheiner P; Müller MW; Homuth K; Büchler MW
Int J Pancreatol; 1998 Apr; 23(2):115-23. PubMed ID: 9629509
[TBL] [Abstract][Full Text] [Related]
29. [Effectiveness of panzytrat--modern physiological enzyme preparation in complex therapy of pancreatic exocrine secretory insufficiency in cholelithiasis].
Petukhov VA; Mironov AV; Semenov ZhS; Ustinov FS
Eksp Klin Gastroenterol; 2009; (1):72-80. PubMed ID: 19551960
[TBL] [Abstract][Full Text] [Related]
30. [Efficacy of a new microencapsulated pancreatin versus a conventional preparation, in the treatment of steatorrhea of pancreatic origin].
Aparisi L; Rodrigo JM; Serra MA; Del Olmo J; Bisquert M; Raga F
Rev Esp Enferm Apar Dig; 1989 Jul; 76(1):25-30. PubMed ID: 2799034
[TBL] [Abstract][Full Text] [Related]
31. Replacement therapy in pancreatic insufficiency with a new pancreatin preparation respecting the physiological ratio of lipase/trypsin activity.
Pap A; Varró V
Hepatogastroenterology; 1988 Apr; 35(2):83-6. PubMed ID: 3371850
[TBL] [Abstract][Full Text] [Related]
32. Placebo controlled trial of enteric coated pancreatin microsphere treatment in patients with unresectable cancer of the pancreatic head region.
Bruno MJ; Haverkort EB; Tijssen GP; Tytgat GN; van Leeuwen DJ
Gut; 1998 Jan; 42(1):92-6. PubMed ID: 9505892
[TBL] [Abstract][Full Text] [Related]
33. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
Spencer TJ; Wilens TE; Biederman J; Weisler RH; Read SC; Pratt R
Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
[TBL] [Abstract][Full Text] [Related]
34. [Pancreatic enzyme substitution in patients with mucoviscidosis].
Henker J
Gastroenterol J; 1990; 49(4):151-5. PubMed ID: 2184824
[TBL] [Abstract][Full Text] [Related]
35. [Effect of pancreatic substitutes on fecal and serum elastase and on pain in patients with chronic pancreatitis].
Aleryani S; Duris I; Payer J; Huorka M; Tesar T; Kratochvíĺová H; Ondrejka P
Vnitr Lek; 2000 May; 46(5):263-7. PubMed ID: 11227180
[TBL] [Abstract][Full Text] [Related]
36. Randomised clinical trial: a 1-week, double-blind, placebo-controlled study of pancreatin 25 000 Ph. Eur. minimicrospheres (Creon 25000 MMS) for pancreatic exocrine insufficiency after pancreatic surgery, with a 1-year open-label extension.
Seiler CM; Izbicki J; Varga-Szabó L; Czakó L; Fiók J; Sperti C; Lerch MM; Pezzilli R; Vasileva G; Pap A; Varga M; Friess H
Aliment Pharmacol Ther; 2013 Apr; 37(7):691-702. PubMed ID: 23383603
[TBL] [Abstract][Full Text] [Related]
37. [Comparative study of the effect of kreon and cotazyme forte in children with cystic fibrosis].
Zsíros J; Sólyom E
Orv Hetil; 1988 May; 129(19):995-9. PubMed ID: 3290773
[No Abstract] [Full Text] [Related]
38. [Substitution therapy in insufficient external pancreatic secretion].
Simek I; Duda M; Kubias K
Vnitr Lek; 1993 Mar; 39(3):250-2. PubMed ID: 8506676
[TBL] [Abstract][Full Text] [Related]
39. Exocrine pancreas disfunction in severely traumatised patients and early enteral nutrition.
Senkal M; Ceylan B; Deska T; Marpe B; Geier B
Ulus Travma Acil Cerrahi Derg; 2008 Jan; 14(1):34-9. PubMed ID: 18306065
[TBL] [Abstract][Full Text] [Related]
40. Exocrine pancreatic function after total gastrectomy in rat.
Hashimoto N
Hepatogastroenterology; 2009; 56(94-95):1274-6. PubMed ID: 19950776
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
